Cryopreservation and Biobanking of Stem Cells
Quick Facts
| Feature | Information |
|---|---|
| Purpose | Long-term preservation of stem cell lines |
| Storage Temperature | ≤ -150°C (Liquid Nitrogen) |
| Common Cryoprotectant | 10% DMSO |
| Preferred Banking Strategy | Master Cell Bank (MCB) + Working Cell Bank (WCB) |
| Recommended Cooling Rate | Approximately -1°C/min |
| Major Applications | Stem cell repositories, disease modeling, regenerative medicine, cell therapy |
Overview
Cryopreservation enables long-term storage of living stem cells while preserving viability, genetic stability, and functional characteristics. Biobanking provides systematic storage, documentation, quality control, and distribution of validated stem cell lines.
Reliable cryopreservation is essential for maintaining reproducibility, minimizing culture-induced genetic changes, and ensuring long-term availability of valuable cell lines.
Why Cryopreserve Stem Cells?
Major benefits include:
- Long-term preservation
- Maintenance of genetic stability
- Experimental reproducibility
- Backup against contamination or culture loss
- Reduced culture-induced mutations
- Easier sharing between laboratories
- Regulatory compliance for clinical research
Principles of Cryopreservation
Successful cryopreservation minimizes cellular damage caused by freezing.
Major Sources of Cellular Injury
| Cause | Effect |
|---|---|
| Ice crystal formation | Membrane damage |
| Osmotic stress | Cell dehydration and injury |
| Thermal shock | Reduced viability |
Controlled-rate freezing combined with appropriate cryoprotective agents greatly improves post-thaw survival.
Cryoprotective Agents
| Cryoprotectant | Typical Use |
|---|---|
| DMSO | Standard cryoprotectant (10%) |
| Glycerol | Selected cell types |
| Commercial Cryomedia | Ready-to-use, serum-free or xeno-free formulations |
Common Freezing Medium
- 90% FBS
- 10% DMSO
For clinical or translational applications, chemically defined xeno-free cryopreservation media are preferred.
Stem Cell Banking Strategy
Master Cell Bank (MCB)
- Early-passage cells
- Fully characterized
- Long-term archival storage
- Used only to generate working stocks
Working Cell Bank (WCB)
- Expanded from the MCB
- Used for routine experiments
- Preserves integrity of the master stock
Recommended Workflow
Validated Cell Line
↓
Master Cell Bank
↓
Working Cell Bank
↓
Experimental Cultures
Pre-Freezing Quality Control
Cells should only be banked after passing quality control.
| Parameter | Recommendation |
|---|---|
| Morphology | Healthy cultures only |
| Viability | >90% |
| Mycoplasma | Negative |
| Identity | Verified |
| Karyotype | Recommended for PSCs |
| Pluripotency | Confirm where applicable |
Recommended Cell Numbers
| Cell Type | Typical Cells/Vial |
|---|---|
| iPSCs | 0.5-2 × 10⁶ |
| NPCs | 1-5 × 10⁶ |
| Astrocytes | 1-3 × 10⁶ |
| Microglia | 1-3 × 10⁶ |
| OPCs | 1-3 × 10⁶ |
Storage Conditions
| Storage Method | Purpose |
|---|---|
| -80°C | Temporary storage |
| Liquid nitrogen vapor phase | Preferred long-term storage |
| Liquid nitrogen liquid phase | Long-term storage (higher contamination risk if improperly managed) |
Post-Thaw Quality Assessment
Following recovery, evaluate:
- Cell viability
- Morphology
- Attachment efficiency
- Growth rate
- Colony formation (for PSCs)
- Recovery of expected marker expression
ROCK inhibitor (Y-27632) is commonly used during recovery of pluripotent stem cells to improve survival after thawing.
Documentation and Authentication
Each cryovial should include:
- Cell line name
- Clone ID
- Passage number
- Freeze date
- Operator
Maintain records of:
- Donor/source information
- Reprogramming or differentiation method
- Gene editing status
- Disease genotype (if applicable)
Authentication before distribution should include:
- STR profiling (human cell lines)
- Mycoplasma testing
- Karyotyping (recommended for PSCs)
- Verification of lineage or pluripotency markers
Best Practices
- Freeze early-passage cultures
- Create both Master and Working Cell Banks
- Store multiple backup vials
- Maintain duplicate storage locations
- Perform routine mycoplasma testing
- Keep complete documentation for every stored vial
Common Problems
| Problem | Possible Cause | Recommended Solution |
|---|---|---|
| Low post-thaw viability | Poor freezing or DMSO toxicity | Controlled-rate freezing, minimize DMSO exposure |
| Poor colony recovery | Cellular stress | Use ROCK inhibitor and optimize culture conditions |
| Genetic drift | Excessive passaging | Return to Master Cell Bank periodically |
| Mycoplasma contamination | Contaminated cultures or reagents | Routine screening and strict aseptic technique |
References
- International Stem Cell Banking Initiative (ISCBI) Guidelines.
- Hunt CJ. Cryopreservation of Human Stem Cells for Clinical Application. Methods in Molecular Biology (2011).
- Baust JM et al. Advances in Cryopreservation of Stem Cells. Transfusion Medicine and Hemotherapy (2009).
- Stacey GN et al. Banking Stem Cells for Research and Clinical Applications. Stem Cell Research (2013).
Repository Tags: stem-cells, cryopreservation, biobanking, ipsc, hesc, cell-banking, liquid-nitrogen, master-cell-bank, working-cell-bank, quality-control, regenerative-medicine